Altimmune, Inc. (ALT)
2.795
-0.06
(-2.10%)
USD |
NASDAQ |
May 18, 11:20
Altimmune Total Assets (Quarterly) : 335.63M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly & Co. | 116.58B |
| Madrigal Pharmaceuticals, Inc. | 1.227B |
| Amgen, Inc. | 92.50B |
| Verastem, Inc. | 227.81M |
| Karyopharm Therapeutics, Inc. | 131.42M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 51.64M |
| Shareholders Equity (Quarterly) | 283.99M |
| Debt to Equity Ratio | 0.1262 |
| Current Ratio | 29.54 |
| Net Debt Paydown Yield | -1.70% |